Indefinite Delivery Contract HT940625DE003
Award Date 10/1/25
Last Date to Order 4/30/31
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Roche Diagnostics Corporation was awarded a single-award Indefinite Delivery Contract by the Defense Health Agency on October 1, 2021, for the supply of histology test reagents and Roche Diagnostics Ventana Medical System platform reagents. The indefinite delivery vehicle maintains a ceiling value of $1,774,824.38 and extends through September 30, 2026, with no set-aside designation. The contract was awarded on an open competitive basis and represents a firm-fixed-price arrangement under which...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Health Agency (DHA), a defense agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $3.66 million, single-award IDC provides an indefinite quantity of immunohistochemical (IHC) testing services, slide stainers, cytology/histology reagents, and associated consumables in support of the Naval Medical Center in Portsmouth, Virginia. The...
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and laboratory instruments, received a single-award Indefinite Delivery Contract from the Defense Health Agency (DHA) on October 1, 2023, with a ceiling value of $7.42 million and an ultimate completion date of June 30, 2028. The contract procures chemistry reagents to support laboratory diagnostic operations across military and defense healthcare systems. The IDV does not utilize small business set-asides,...
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and laboratory reagents, was awarded a single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract by the Defense Health Agency on September 23, 2022, with a ceiling value of $6.5 million and an ultimate completion date of September 22, 2027. The contract covers Roche Diagnostics Laboratory Library Preparation Kits and related consumable laboratory test and quantification materials. The primary places of...
- The Defense Health Agency awarded a single-award Indefinite Delivery Contract to Roche Diagnostics Corporation on October 1, 2023, with a ceiling value of $10,938,777.37 and an ultimate completion date of September 30, 2028. This contract procures chemistry and immunoassay testing supplies and services under a cost-per-reportable-result pricing model. Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical...
- The Defense Health Agency awarded a single-award Blanket Purchase Agreement to Roche Diagnostics Corporation for the leasing of tissue staining equipment, services, and reagents with a ceiling value of $20,000,000 and a period of performance through May 4, 2030. This contract was awarded on May 1, 2025, without any set-aside designation, allowing Roche to compete openly in the federal marketplace. The contract vehicle enables the Defense Health Agency to efficiently procure diagnostic laboratory...
- The Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and medical products. The $4.4 million IDC, which has no set-aside designation, provides for the delivery of Roche's medical diagnostic technologies, including laboratory equipment, testing systems, reagents, and clinical testing services, to support healthcare delivery...
- The provided information details an Indefinite Delivery Contract (IDC) awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, laboratory instruments, and associated products and services. The 5-year, $9,160,241.71 IDC allows DHA to issue delivery orders for Roche's Total Laboratory Automation Systems and Cobas 8000 analyzers to support operations at Madigan Army Medical Center in Tacoma, Washington. Under the IDC,...
- Roche Diagnostics Corporation was awarded a single-award Indefinite Delivery Contract by the Defense Health Agency, with an ultimate completion date of September 30, 2028, and a ceiling value of approximately $6.0 million. The contract supports the supply of reagents, consumables, training, and maintenance services for a government-owned Roche Diagnostic Total Laboratory Automation system located at Madigan Army Medical Center. The contracted system comprises multiple Cobas Pro analytical...
- This Indefinite Delivery Contract (IDC) was awarded by the National Institutes of Health (NIH) Clinical Center to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract has a ceiling value of $680,070 and a period of performance from September 1, 2024 to August 31, 2026. The purpose of this single-award IDC is to provide the NIH Clinical Center Department of...